Omicron Vaccine
-
{
- All
- News
- Videos
-
Cicada COVID Variant BA. 3.2: Why Children Are 5 Times More Likely To Get Infected And Tips To Safeguard Them
The new cicada COVID variant BA.3.2 can infect children 5 times more than the Omicron variant. This is why you need to get your children a booster dose and follow the established protocol to safeguard them.
-
Cicada Vs Previous Omicron Strains: What's Truly Different Between The Covid-19 Variants?
Unlike early Omicron strains such as BA.1 and BA.2, Cicada has more changes that might help it dodge immunity from vaccines or past infections.
-
Covid-19 Cicada Variant: Can Current Vaccines Protect Against BA.3.2 Subvariant?
The BA.3.2 sub-variant was first detected in South Africa in late 2024. The variant has been detected in at least 23 countries worldwide.
-
New Cicada Covid-19 Variant BA.3.2 Detected In The US: Key Facts, Symptoms, Risk Factors Explained
A new Covid-19 subvariant, BA.3.2, nicknamed Cicada, is being tracked in the US and other countries. Experts say it carries multiple mutations, may evade immunity, but currently shows no clear rise in severe illness.
-
Covid Variants Over Time: Alpha To Omicron To Stratus, Tracked And Explained
Since SARS-CoV-2 first emerged in late 2019 the virus has spawned dozens of lineages, a handful of global "variants of concern" that changed the course of the pandemic.
-
All About COVID-19 Variant 'Stratus' That Is Fuelling Cases In US
As per the WHO, the currently approved COVID-19 vaccines are expected to remain effective against this variant.
-
Covid-19 In India: LF.7 and NB.1.8.1, New Covid Variants Detected; Do You Need A Booster Dose?
The JN.1 variant and its related descendants belong to the Omicron family.
-
China's Wuhan Lab Creates New Vaccine For 'Future Pandemics': "Universal Protection"
Scientists at the institute have developed a new nanovaccine that shows promise in providing universal protection against all major Covid-19 variants.
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
India Records 5,880 Covid Cases In 24 Hours: Do Not Ignore These Symptoms Of The XBB.1.16 Variant
The new Covid-19 variant, XBB.1.16 is responsible for the surge in cases in India. According to the Health Ministry data, India has reported a total of 5,880 covid cases in the last 24 hours.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Up To 70% Of Those Under 19 Globally Susceptible To Covid: Study
Fifty to 70 per cent "children" below 19 years globally were susceptible to the SARS-CoV-2 infection by the end of 2021 and before the Omicron wave, showing a need for more effective vaccines and better vaccination coverage, according to a study.
-
Despite Vaccine Strides, India Opt Out Of Covid Shadow Yet
Just when the world was starting to believe that the novel coronavirus pandemic, the deadly new Omicron BF.7 strain reinforced the home truth that the world has certainly not seen the last of the pandemic.
-
Administering 220 Crore Doses Of Covid Vaccine In India Highpoint Of 2022
2022 saw a new wave of infections driven by the Omicron variant of coronavirus which ultimately subsided, putting India along with the world on the route to normalcy before fresh concerns arose amid rise in cases globally at the fag end of the year.
-
'Bivalent' Booster For Omicron, Original Covid Strain Approved By UK
The UK health authorities on Saturday approved a second "bivalent" vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19.
-
Cicada COVID Variant BA. 3.2: Why Children Are 5 Times More Likely To Get Infected And Tips To Safeguard Them
The new cicada COVID variant BA.3.2 can infect children 5 times more than the Omicron variant. This is why you need to get your children a booster dose and follow the established protocol to safeguard them.
-
Cicada Vs Previous Omicron Strains: What's Truly Different Between The Covid-19 Variants?
Unlike early Omicron strains such as BA.1 and BA.2, Cicada has more changes that might help it dodge immunity from vaccines or past infections.
-
Covid-19 Cicada Variant: Can Current Vaccines Protect Against BA.3.2 Subvariant?
The BA.3.2 sub-variant was first detected in South Africa in late 2024. The variant has been detected in at least 23 countries worldwide.
-
New Cicada Covid-19 Variant BA.3.2 Detected In The US: Key Facts, Symptoms, Risk Factors Explained
A new Covid-19 subvariant, BA.3.2, nicknamed Cicada, is being tracked in the US and other countries. Experts say it carries multiple mutations, may evade immunity, but currently shows no clear rise in severe illness.
-
Covid Variants Over Time: Alpha To Omicron To Stratus, Tracked And Explained
Since SARS-CoV-2 first emerged in late 2019 the virus has spawned dozens of lineages, a handful of global "variants of concern" that changed the course of the pandemic.
-
All About COVID-19 Variant 'Stratus' That Is Fuelling Cases In US
As per the WHO, the currently approved COVID-19 vaccines are expected to remain effective against this variant.
-
Covid-19 In India: LF.7 and NB.1.8.1, New Covid Variants Detected; Do You Need A Booster Dose?
The JN.1 variant and its related descendants belong to the Omicron family.
-
China's Wuhan Lab Creates New Vaccine For 'Future Pandemics': "Universal Protection"
Scientists at the institute have developed a new nanovaccine that shows promise in providing universal protection against all major Covid-19 variants.
-
Gennova mRNA Covid Booster Vaccine Gets Emergency Use Authorisation
Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.
-
India Records 5,880 Covid Cases In 24 Hours: Do Not Ignore These Symptoms Of The XBB.1.16 Variant
The new Covid-19 variant, XBB.1.16 is responsible for the surge in cases in India. According to the Health Ministry data, India has reported a total of 5,880 covid cases in the last 24 hours.
-
Covovax To Get Approval As Covid Booster In 10-15 Days: Adar Poonawalla
Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.
-
Up To 70% Of Those Under 19 Globally Susceptible To Covid: Study
Fifty to 70 per cent "children" below 19 years globally were susceptible to the SARS-CoV-2 infection by the end of 2021 and before the Omicron wave, showing a need for more effective vaccines and better vaccination coverage, according to a study.
-
Despite Vaccine Strides, India Opt Out Of Covid Shadow Yet
Just when the world was starting to believe that the novel coronavirus pandemic, the deadly new Omicron BF.7 strain reinforced the home truth that the world has certainly not seen the last of the pandemic.
-
Administering 220 Crore Doses Of Covid Vaccine In India Highpoint Of 2022
2022 saw a new wave of infections driven by the Omicron variant of coronavirus which ultimately subsided, putting India along with the world on the route to normalcy before fresh concerns arose amid rise in cases globally at the fag end of the year.
-
'Bivalent' Booster For Omicron, Original Covid Strain Approved By UK
The UK health authorities on Saturday approved a second "bivalent" vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19.
